Kodiak Sciences KOD
NASDAQ KOD
$35.36 -1.00 (-2.75%)
As of: Sep 4, 2026 · 3:59 PM EDT

Kodiak Sciences (KOD) Enterprise Value (2018 - 2026)

Kodiak Sciences' (KOD) quarterly Enterprise Value came in at -$169.5 million in Q1 2026, down 22.09% YoY from -$217.6 million in Q1 2025, and up 19.22% on a QoQ basis from -$209.9 million in Q4 2025.

Analysis

Kodiak Sciences (KOD) Enterprise Value (2018 - 2026) Analysis & Trends

Kodiak Sciences (KOD) has 10 years of Enterprise Value data on file, last reported at -$169.5 million in Q1 2026.

  • Quarterly Enterprise Value fell 22.09% year-over-year to -$169.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$169.5 million (down 22.09% YoY) and the FY2025 annual result came in at -$209.9 million, down 24.86% from the prior year.
  • Enterprise Value improved to -$169.5 million in Q1 2026, from -$209.9 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$72.0 million in Q3 2025 to a low of -$671.7 million in Q1 2022.
  • A 5-year average of -$308.8 million and a median of -$245.9 million in 2024 frame the typical range for Enterprise Value.
  • The widest YoY moves for Enterprise Value: up 63.59% in 2025, down 24.86% in 2025.
  • Tracing KOD's Enterprise Value over 5 years: stood at -$485.3 million in 2022, then surged by 41.16% to -$285.5 million in 2023, then soared by 41.13% to -$168.1 million in 2024, then decreased by 24.86% to -$209.9 million in 2025, then advanced by 19.22% to -$169.5 million in 2026.
  • The last three Enterprise Value figures came in at -$169.5 million (Q1 2026), -$209.9 million (Q4 2025), and -$72.0 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Kodiak Sciences 2.21 Bn 2.21 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.32 Bn
Mar 31, 2026 2.20 Bn
Dec 31, 2025 1.52 Bn
Sep 30, 2025 795.55 Mn
Jun 30, 2025 92.86 Mn
Mar 31, 2025 9.38 Mn
Dec 31, 2024 356.56 Mn
Sep 30, 2024 -60.52 Mn
Jun 30, 2024 -95.58 Mn
Mar 31, 2024 30.35 Mn
Dec 31, 2023 -125.88 Mn
Sep 30, 2023 -251.23 Mn
Jun 30, 2023 -16.74 Mn
Mar 31, 2023 -96.65 Mn
Dec 31, 2022 -110.55 Mn
Sep 30, 2022 -132.56 Mn
Jun 30, 2022 -200.41 Mn
Mar 31, 2022 -270.75 Mn
Dec 31, 2021 3.66 Bn
Sep 30, 2021 4.16 Bn